Tig Advisors, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Tig Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $4.09 Million - $4.3 Million	-28,215 Reduced 2.74%	1,001,653 $151 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $47.4 Million - $83.3 Million	570,454 Added 124.17%	1,029,868 $150 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $11.1 Million - $14.7 Million	-297,684 Reduced 39.32%	459,414 $19.2 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $30.1 Million - $50.7 Million	757,098 New	757,098 $33.2 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Tig Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tig Advisors, LLC with notifications on news.